| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/26/2011 | EP2277890A1 Peptide capable of extending half-life of peptide of interest in plasma |
| 01/26/2011 | EP2277889A2 Fusion proteins of albumin and interferon beta |
| 01/26/2011 | EP2277888A2 Fusion proteins of albumin and erythropoietin |
| 01/26/2011 | EP2277535A2 Vaccine |
| 01/26/2011 | EP2277534A1 Immunogenic and therapeutic compositions for streptococcus suis |
| 01/26/2011 | EP2277533A2 Methods for vaccinating against malaria |
| 01/26/2011 | EP2277532A1 Novel composition and methods for the treatment of immune related diseases |
| 01/26/2011 | EP2277530A1 Glucagon-like peptide-2 and its therapeutic use |
| 01/26/2011 | EP2277527A2 Peptide YY analogs |
| 01/26/2011 | EP2277050A1 Analysis of amino acid copolymer compositions |
| 01/26/2011 | EP2276847A2 Method for manufacturing an aqueous glucose solution |
| 01/26/2011 | EP2276845A1 Method for manufacturing l-amino acids |
| 01/26/2011 | EP2276830A1 Functional enhancement of yeast to minimize production of ethyl carbamate via modified transporter expression |
| 01/26/2011 | EP2276778A1 Neurotrophic factor manf and uses thereof |
| 01/26/2011 | EP2276503A2 Citrullinated cytokines |
| 01/26/2011 | EP2129684B1 Method of purification of hydrophobic proteins |
| 01/26/2011 | EP2094845B1 Artificial binding proteins based on a modified alpha helical region of ubiquitin |
| 01/26/2011 | EP1912665B1 Vaccine against feline calicivirus (fcv) comprising a fcv capsid protein or an isolated fcv capsid protein comprising protein sequence seq id no: 13 or protein sequences having at least 95% identity thereto. |
| 01/26/2011 | EP1907419B1 Preparation of insulin conjugates |
| 01/26/2011 | EP1842066B1 Biologically active silver-coated proteins |
| 01/26/2011 | EP1817337B1 Therapeutic peptides comprising sequences derived from cdr2 or cdr3 of trem-1 and uses thereof to inhibit sepsis |
| 01/26/2011 | EP1725261B1 Use of agonists and antagonists of interleukin-33 (il-33) |
| 01/26/2011 | EP1711603B1 Transformed saccharomyces cerevisiae and method for mass-production of lk8 protein using the same |
| 01/26/2011 | EP1692288B1 A novel l-threonine importer from corynebacterium and a preparation method of a strain producing l-threonine |
| 01/26/2011 | EP1660513B1 A ca6 antigen-specific cytotoxic conjugate and methods of using the same |
| 01/26/2011 | EP1636583B1 Human g protein-coupled receptor and modulators thereof for the treatment of cardiovascular disorders |
| 01/26/2011 | EP1581649B1 Binding agents which inhibit myostatin |
| 01/26/2011 | EP1578778B1 Ghrelin analogs |
| 01/26/2011 | EP1556489B1 Pharmaceutical composition for preparing a medicine for treating and/or preventing a pathology related to an obsessive behaviour or obesity |
| 01/26/2011 | EP1539956B1 GEF-H1b: BIOMARKERS, COMPLEXES, ASSAYS AND THERAPEUTIC USES THEREOF |
| 01/26/2011 | EP1434493B2 Flax protein isolate and production |
| 01/26/2011 | EP1404365B1 Methods and compositions for inhibiting, preventing, or reducing tumor cell growth in patients resistant to the antineoplastic effects of antiestrogen therapy |
| 01/26/2011 | EP1303186B1 Medicinal uses of mu-opioid receptor agonists |
| 01/26/2011 | EP1289545B1 Synthetic vaccine for tick control |
| 01/26/2011 | EP1192180B1 Product from starfish |
| 01/26/2011 | EP1179004B1 Potassium channel kcnq5 |
| 01/26/2011 | EP1002051B1 Probiotic strains from lactobacillus salivarius and antimicrobial agents obtained therefrom |
| 01/26/2011 | EP0951552B1 Dna and specific proteins or peptides of the neisseria meningitidis species bacteria, method for obtaining them and their biological applications |
| 01/26/2011 | EP0948625B1 Uspa1 and uspa2 antigens of moraxella catarrhalis |
| 01/26/2011 | EP0946725B1 Receptor activator of nf-kappa b, receptor is member of tnf receptor superfamily |
| 01/26/2011 | CN1934265B Process for the production of l-amino acids using coryneform bacteria |
| 01/26/2011 | CN1934128B Process for producing human serum albumin by heating in presence of divalent cation |
| 01/26/2011 | CN1749274B Separating and purifying method for new recombinant human interferon alpha2b |
| 01/26/2011 | CN101960309A Composition and method for diagnosis or detection of gastric cancer |
| 01/26/2011 | CN101960014A Cell lines and methods for making and using them |
| 01/26/2011 | CN101960011A Use of plastid transit peptides derived from Glaucocystophytes |
| 01/26/2011 | CN101960010A Mutant gene capable of controlling the oil-and-fat content in seed, and method for controlling the oil-and-fat content in seed |
| 01/26/2011 | CN101959526A Use of interleukin-1 conjugates in the treatment of diabetes |
| 01/26/2011 | CN101959419A Novel bacillus thuringiensis gene with coleopteran activity |
| 01/26/2011 | CN101957376A Colloidal gold chromatography test paper for rapidly detecting guanidineacetic acid and derivatives thereof and preparation method thereof |
| 01/26/2011 | CN101955962A Method for expressing biotinylated antigen |
| 01/26/2011 | CN101955950A Method for preparing recombinant fibrin-related antigen of egg drop syndrome viruses |
| 01/26/2011 | CN101955949A Arabidopsis thaliana transcription factor gene as well as recombinant expression vector and application thereof |
| 01/26/2011 | CN101955947A Application of plant sodium-calcium exchanger gene (AtNCL) |
| 01/26/2011 | CN101955941A Porcine interferon gene family and application thereof in blue-ear porcine disease resistant medicament and vaccine adjuvant |
| 01/26/2011 | CN101955528A Human MCHR1 epitope domain gene expression-associated protein MCHR1-C and encoding gene thereof |
| 01/26/2011 | CN101955527A Novel insulin derivatives |
| 01/26/2011 | CN101955526A Pseudosciaena crocea MSTN-1 (Myostatin) propeptide, propeptide antibody and preparation method thereof |
| 01/26/2011 | CN101955525A Artificial antimicrobial peptide, gene and preparation method thereof |
| 01/26/2011 | CN101955524A CNGH0010 specific polynucleotides, polypeptides, antibodies, compositions, methods and uses |
| 01/26/2011 | CN101955523A Preparation and application of Eriocheir sinensis whey acidic protein (WAP) with bacteriostatic activity |
| 01/26/2011 | CN101955522A Peanut ferrous transport protein as well as encoding gene and application thereof |
| 01/26/2011 | CN101955521A Plant stress tolerance associated protein, and coded genes and application thereof |
| 01/26/2011 | CN101955520A Drought resistant and salt tolerant plant protein, encoding gene and application thereof |
| 01/26/2011 | CN101955519A Plant DREB transcription factor, coding gene thereof and use thereof |
| 01/26/2011 | CN101955518A Populus diversifolia NAC protein, gene coding sequence thereof and application thereof |
| 01/26/2011 | CN101955517A Method for extracting and purifying microcystin |
| 01/26/2011 | CN101955516A Method for preparing microcystin-LR |
| 01/26/2011 | CN101955468A Melamine hapten, melamine complete antigen and preparation method thereof |
| 01/26/2011 | CN101481691B Trichinella spiralis 70KDa heat shock protein and use thereof |
| 01/26/2011 | CN101445789B Application of dominant negative mutant F427N as anthrax toxin inhibitor and vaccine |
| 01/26/2011 | CN101397565B Rice high affinity nitrate transport protein gene OsNAR2.1 |
| 01/26/2011 | CN101328204B Preparation of dioctyl phthalate artificial antigen |
| 01/26/2011 | CN101318990B Synthesis of multi-antigenic determinant artificial antigen with aminoglycoside medicaments |
| 01/26/2011 | CN101161816B Plant expression carrier construction for divalent insect-resistant gene and transgenic plant acquiring method thereof |
| 01/25/2011 | US7875780 Inbred corn line LLD20BM |
| 01/25/2011 | US7875710 Nucleic acids encoding platelet derived growth factor receptor alpha (PDGFRA) activating mutations |
| 01/25/2011 | US7875709 Nucleic acids encoding interleukin-18 mutants |
| 01/25/2011 | US7875703 Comprises nucleotide sequences coding antibody receptor for treating autoimmune and immunological diseases |
| 01/25/2011 | US7875702 B7-H3 and B7-H4, novel immunoregulatory molecules |
| 01/25/2011 | US7875591 comprising a scaffold coated with a protein having at least 83% identity to the amino acid sequence of the core protein of domain I of a mammalian perlecan, wherein at least one glycosaminoglycan is attached to the protein; induce replication and/or differentiation of connective tissue cells |
| 01/25/2011 | US7875590 using an injectable or implantable rod-shaped formulation for delivery of osteogenic proteins to treat osteoporotic and/or osteopenic bone; bone morphogenic proteins |
| 01/25/2011 | US7875587 such as type 2 diabetes, obesity, insulin resistance; stimules insulin release; dipeptidyl peptidase-IV resistant gastric inhibitory peptide (GIP) analog |
| 01/25/2011 | US7875585 Hematopoietic cell E-selectin / L-selectin ligand glycosylated CD44 polypeptide |
| 01/25/2011 | US7875450 Virus-like particles for the induction of autoantibodies |
| 01/25/2011 | US7875444 Lignin blockers and uses thereof |
| 01/25/2011 | US7875443 nitrilases, amine protectants; hydrolysis |
| 01/25/2011 | US7875439 Nucleotide sequences coding bacterial surface protein for use in development of vaccines and prevention of infection |
| 01/25/2011 | US7875438 Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics |
| 01/25/2011 | US7875437 Expression vector comprising nucleotide sequences coding streptococcal surface protein for use in detection, prevention and treatment of microorganismal infection |
| 01/25/2011 | US7875436 immobilization; solid phase synthesis; kits |
| 01/25/2011 | US7875424 Identification of tumour-associated cell surface antigens for diagnosis and therapy |
| 01/25/2011 | US7875423 hepatitis b virus (HBV) variants with reduced sensitivity to agents and/or reduced interactivity with immunological reagents; detecting adefovir dipivoxil resistance |
| 01/25/2011 | US7875421 determining probiotic properties |
| 01/25/2011 | US7875279 intermediates of the mevalonate-independent pathway for isoprenoid biosynthesis are enriched by deleting or inactivating genes; asthma, morbus Crohn, colitis ulcerosa, multiple sclerosis and chronic bronchitis and immune and auto-immune diseases and allergies and bone diseases and osteoporosis |
| 01/25/2011 | US7875259 Generating prion specific immunoglobulin for use in diagnosis, prevention and treatment of neurodegenerative disorders |
| 01/25/2011 | CA2635963C Human monoclonal antibody against a costimulatory signal transduction molecule ailim and pharmaceutical use thereof |
| 01/25/2011 | CA2529965C Modified viral particles with immunogenic properties and reduced lipid content useful for treating and preventing infectious diseases |
| 01/25/2011 | CA2525499C Ligand (act-4-l) to a receptor on the surface of activated cd4+ t-cells |
| 01/25/2011 | CA2495743C Fusion proteins and methods of producing same |